Microbial balance for human and animal health
The concept of interdependence of microbes, viruses and fungi with their host has a fundamental link with health.
One health concept: the link between humans, animals and environment
With over a decade of dedicated expertise, Vibiosphen stands as a leading authority in the field of infectious diseases, championing an integrated One Health strategy that bridges the gap between human and animal health. Our comprehensive approach reflects a deep understanding of the interconnected nature of ecosystems, emphasizing the critical importance of holistic health management to tackle infectious diseases effectively.
Explore our innovative models through microbiology expertise
At Vibiosphen, we are specialized in creating and applying sophisticated preclinical models meticulously designed to mimic real-life clinical scenarios. Our extensive portfolio includes detailed animal models, state-of-the-art in vitro systems, advanced microbiota analysis, and innovative organoid technologies. This suite of multidisciplinary models allows us to comprehensively study and respond to the complex dynamics of infectious pathogens, including bacteria, viruses, fungi, and particularly those related to antimicrobial resistance.
By fighting antimicrobial resistance, we act for tomorrow’s global health
As antimicrobial resistance continues to bring significant global threats and viral infections emerge as increasingly serious challenges to society, Vibiosphen remains steadfastly committed to innovation and scientific excellence. Our robust research frameworks and rigorous testing protocols drive meaningful contributions to global health advancements, fostering sustainable solutions in disease management through translational preclinical tools.
Redefining our understanding of resistance and viral infections through innovation.
Bacteria
Gram negative and Gram positive, aerobic/anaerobic, pathogenic/commensal resistant bacterial strains, ESKAPE.
Human and animal health expertise
We collaborate closely with pharmaceutical companies, biotech firms, research institutions, and public health organizations worldwide, assisting in accelerating the development and validation of novel therapeutics, and preventive strategies.
